We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAAM.L Regulatory News (AAM)

  • There is currently no data for AAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

22 May 2019 10:07

RNS Number : 8455Z
Artemis VCT PLC
22 May 2019
 

ARTEMIS VCT PLC

Legal Entity Identifier: 549300R6443VUTMRCP48

Half-Yearly Financial Report (unaudited) for the six months ended 31 March 2019

 

This announcement contains regulated information

 

Financial Highlights

 

 

As at

31 March 2019

As at

31 March 2018

As at

30 September 2018

Net assets

£25.0m

£40.0m

£34.2m

Net asset value per ordinary share

47.24p

75.27p

64.40p

Share price

43.50p

74.50p

71.00p

(Discount)/Premium

(7.9)%

1.0%

10.2%

VCT qualifying holdings percentage

83.2%

87.0%

99.4%

Ongoing charges

2.7%

2.2%

2.4%

 

 

 

Dividends per share

As at

31 March 2019

As at

31 March 2018

As at

30 September 2018

Ordinary dividend

2.00p

2.00p

4.00p

Special dividend

1.00p

8.00p

17.00p

Cumulative dividends since launch*

116.20p

102.20p

113.20p

 

 

 

Total returns

 

6 months

 

1 year

 

3 years

 

5 years

 

10 years

Since launch*

Net asset value total return

(18.5)%

(13.0)%

54.9%

94.7%

315.6%

157.9%

Peer group size weighted average return**

 

(17.2)%

 

(7.4)%

 

18.0%

 

27.5%

 

191.3%

 

N/A

Share price total return

(32.7)%

(21.2)%

64.2%

109.0%

362.8%

132.6%

Peer group size weighted average return**

 

(13.0)%

 

(5.2)%

 

26.4%

 

36.4%

 

235.0%

 

N/A

 

Total return is capital appreciation (or depreciation) and any dividends paid by the Company which are deemed to be reinvested.

 

Source: Artemis Fund Managers Limited ('Artemis'), unless otherwise indicated.

**The Association of Investment Companies ('AIC'). Peer group comparison is based on the information published by the AIC on 11 April 2019 as at 31 March 2019.

*24 March 2005.

Alternative Performance Measure

 

Chairman's Statement

 

Performance

Since I last wrote to you six months ago, we have seen performance slip with a net asset value total return loss of 17.3%. The Company's share price total return loss was 32.7% for the six months to 31 March 2019. This compares to a fall in the FTSE AIM All-Share Index of 16.0% over the same period. Sitting at a premium of 10.2% as at 30 September 2018 and hitting a high of 24.5%, at the half year point the Company's share price stood at a discount of 9.0% and currently sits at 11.0%.

 

Whilst the market has been challenging over this period, the performance of your Company has been affected not only by market conditions but also by the downgrading of a number of our investments.

 

Portfolio

During the six month period the Investment Manager kept portfolio activity at a minimal level, making disposals totalling £1.7 million and realising total gains of £1.2m from sales in AB Dynamics, Craneware, Abcam and Pelatro.

 

The environment continues to give limited investment opportunity and no new qualifying investments were made.

 

Further details of the Company's investment activities are provided in the Investment Manager's Review.

 

Dividend

Following the payment of the interim dividend in November 2018, the cash position of your Company has remained steady, leaving the Board the opportunity to invest in attractive propositions should they have arisen. However, as noted above, such opportunities have not appeared and the Board has today declared an interim dividend of 2.00 pence per share and a special dividend of 1.00 pence per share. These will be paid on 30 June 2019, to shareholders on the register on 31 May 2019.

 

Total dividends declared to date by the Company amount to 116.2 pence per share. This comprises 48.2 pence of ordinary dividends and 68.0 pence of special dividends.

 

As noted previously, VCT rules set a time limit on companies holding cash for long periods of time which may lead the Board to return funds to investors when no investment opportunities are presented. The Board however continues to believe that it is in the Company's best interests for the Investment Manager to pursue and prioritise new investment opportunities. It cannot be certain therefore that special dividends will be paid this year to the same extent as in previous years.

Share buybacks

Having had a long period of unchanged share capital, the Company performed two buybacks in the six months to 31 March 2019, followed by a further buyback after the period end on 17 May 2019. The Company will continue to buy back shares within guidelines set by the Board. Share buybacks remain subject to the Company having the necessary shareholder authorities in place and having sufficient cash available for this purpose, taking into account future cash requirements for investing activities, the payment of dividends and operating expenses.

 

Outlook

With the previously announced legislative changes having come in to force on 6 April, the Board continues to closely monitor any impact going forward and does not expect any significant changes to the Company's Investment Policy.

 

As noted in your Investment Manager's Review, the economic outlook could be viewed as gloomy but the Board hold firm to the view that our investments still offer good value; having strong track records with potential to ride the current turbulence and recover strongly.

 

And finally …

I look forward to providing further updates on your Company's performance in the Annual Financial Report 2019 which will be published in December 2019.

 

In the meantime, shareholders can keep up to date by visiting our website (artemisvct.co.uk) to view the monthly factsheet and other articles from the Investment Manager. In addition, the Board is always keen to hear from shareholders. Should you wish to, you can e-mail me at vctchairman@artemisfunds.com.

 

Fiona Wollocombe

Chairman

22 May 2019

 

 

 

Investment Manager's review

 

Performance

It is now 10 years since Artemis AiM VCT plc merged with Artemis AiM VCT 2 plc. That offers a timely opportunity to reflect on the long-term performance of the combined Artemis VCT. Over the last decade, the Company's net asset value (NAV) has fallen from 53.97 pence to 47.24 pence per share, but over that same period dividends of 107 pence per share have been paid. The total return of 100.27 pence per share equates to a return of 186% (equivalent to an annualised return of 11.1%).

This is despite what has undoubtedly been a very difficult recent period in which the NAV has fallen from 64.40 pence at the end of September 2018 to the aforementioned 47.24 pence today. Adding back the 6.0 pence dividend paid in November, this represents a total return of (17.3)% over the last six months.

Review

With widespread losses in equity markets in the final quarter of 2018 and the AIM market declining 16% over the last six months, it would be convenient to attribute the decline in the NAV to conditions in the wider market. Having cautioned on valuations for some time, a pull-back was probably overdue and high-growth stocks were certainly likely to be hit first. Attributing the blame solely to the wider sell-off, however, would be disingenuous. The hostile market conditions were compounded by a number of poor updates from our investments. With substantial profit-taking earlier in the year, we entered the period with 18% of the fund in cash so would have expected to preserve capital better than we did.

Five largest stock detractors

Company

% of

net assets

Contribution

(%)

Proactis Holdings

0.8

(2.36)

Yu Group

0.4

(2.33)

Fulcrum Utility Services

3.3

(2.23)

Dods Group

3.7

(1.97)

ULS Technology

3.5

(1.85)

 

As we highlighted in the last annual report, Yu Group had an accounting review following the appointment of a new finance director. A subsequent independent forensic investigation confirmed serious historic failures in the systems and processes within the company's finance function. Yu Group is now in the process of implementing the report's recommendations. Meanwhile the company continues to trade well, supported by a strong balance sheet. With management focused on a more selective, disciplined approach to growth there remains the prospect of recovering some of the value that has been lost.

 

Proactis also featured in our last annual report but, contrary to our expectations, trading has continued to deteriorate. Losses of contracts and a failure to sign new deals have led to downgrades to expectations for profits. That, in itself, would have been disappointing. In addition, the debt taken on to fund the acquisition of Perfect Commerce has left the company financially stretched. While we expect the company to be able to manage its way through, its recent record has understandably left investors (ourselves included) feeling nervous.

 

Fulcrum Utility Services is also suffering the consequences of a poor acquisition. The purchase of Dunamis a little over a year ago was intended to diversify the group into electrical infrastructure. Certainly the logic of a multi-utility strategy, combining gas and electricity expertise, seemed sound. But the acquisition has underperformed markedly. To be fair to management, this has largely been due to external factors - the EU suspended the capacity market in November. While that would have been difficult to predict at the time of the deal, the share price has nevertheless been hit hard.

 

Market conditions (in the shape of Brexit) are also largely to blame for the underperformance of ULS Technology and Dods Group. As an online provider of conveyancing services, ULS Technology relies on mortgage activity and housing transactions. The company is continuing to gain market share but this is being outweighed by a lacklustre housing market as house buyers exercise caution. Similarly, as the challenge of Brexit dominates the timetable at Westminster, the government's wider policymaking has suffered. As a provider of political information across a range of departments Dods has been caught up in the disruption.

 

 

 

Five largest stock contributors

 

 

Company

% of

net assets

Contribution

(%)

AB Dynamics

4.4

1.18

Pelatro

3.4

0.89

Instem

6.9

0.36

Vianet Group

3.4

0.22

MyCelx Technologies

4.0

0.19

 

That is not to say it has been all doom and gloom. Many of our investee companies continue to make good progress, although the degree to which this has been recognised in share prices varies.

 

Although not among our top five contributors, it would be remiss not to comment on Judges Scientific given its sizeable weighting in the fund. Interestingly, it is one of 11 current holdings that also featured in the portfolio 10 years ago. It was a modest holding back then but over the last six months it has been our largest holding by some margin. Having digested the company's interim results, we were anticipating further upgrades and a full repayment of debt in the coming months. Both were duly delivered, with operating profits coming in over 15% ahead of expectations. In our view, the 6% decline in the share price over the last six months seems unwarranted. We were not inclined to take profits in September and are even less minded to do so now, despite the fact that with falls in other holdings (and the dividends paid out) this holding now represents over 8% of the Company's assets. While we acknowledge the risk that this represents, its strong operational momentum, conservative management team, robust balance sheet and attractive valuation give us comfort that it is a risk worth bearing and one that we feel will be well rewarded.

 

AB Dynamics also continues to go from strength to strength. It too is seeing profit expectations upgraded as safety systems for drivers become more sophisticated, fuelling demand for its products. The new chief executive, James Routh, inherits a business in rude health and we are confident that under his leadership this can be maintained.

 

It is now just over a year since we invested in Pelatro and the company has delivered on the expectations set out at the time. Indeed, a growing number of telecoms companies are adopting Pelatro's software and the acquisition of Danateq has bedded down well.

 

Instem's progress is also being recognised. Having initially been caught up in the wider sell-off, the shares recovered towards their all-time high. Results for 2018 showed a year of profitable growth and expanding margins, with a growing contribution from its new business in technology-enabled outsourced services. Although still embryonic, the potential market is significant and Instem has established a leading position.

 

Vianet has continued to make progress despite a difficult market. Ongoing pub closures have been a headwind, as has the move from upfront capital sales to recurring revenue in the smart machine division. Management deserve credit for managing the transition well with a healthy dividend paid throughout.

 

A more buoyant period for oil prices has been helpful for MyCelx Technologies. The company has survived a difficult period in recent years. In the last 12 months it has been successful in gaining contracts in Saudi Arabia in particular. A small fundraising in February helped strengthen the balance sheet as the company looks to maintain momentum in 2019.

 

Investment activity

In contrast to previous periods, it has been a relatively quiet time in terms of investment activity. No new qualifying investments were made and activity in disposals was subdued.

 

As previously reported, we had been actively taking profits through the first nine months of 2018. We had over £11 million of proceeds from disposals and a similar level of dividends was paid out to shareholders. As such, when the sharp sell-off came in the final quarter of the year we stood back and made no further disposals. As share prices have recovered somewhat in 2019 we took modest profits in AB Dynamics, Craneware, Abcam and Pelatro.

 

As mentioned above, Pelatro is a recent addition to the portfolio so to be selling so soon may look slightly unusual. This reflects the fact that we still consider it to be at an early stage of development so, unlike Judges Scientific, we were uncomfortable with the increased weighting it represented in the Company's portfolio.

 

Outlook

With economic growth slowing, recent performance disappointing and a lack of new investments it would be easy to be pessimistic about the outlook. Yet we are more confident than we were six months ago. Aside from the individual stock issues highlighted, we're not sure an awful lot has changed. The portfolio is largely the same and the majority of our holdings are continuing to grow profits and cashflows under the guidance of long-serving managers. The main difference is that our investments now trade on significantly cheaper valuations. Over the years, we have witnessed many examples of companies recovering well from short-term difficulties and there is no reason to think this time will be any different. So, while the last six months have been uncomfortable we remain committed to the long-term approach that has served us well.

 

Andy Gray

Fund Manager

22 May 2019

 

 

Responsibility statement of the Directors in respect of the Half-Yearly Financial Report

 

The Directors confirm that to the best of their knowledge in respect of the Half-Yearly Financial Report for the six months ended 31 March 2019:

 

the condensed set of financial statements has been prepared in accordance with the Financial Reporting Standard ('FRS') 104: 'Interim Financial Reporting'; having considered the expected cash flows and operational costs of the Company for the 18 months from the period end, the Directors are satisfied that the Company has adequate resources to continue in operational existence for the foreseeable future. For this reason the going concern basis of accounting continues to be used in the preparation of the Half-Yearly Financial Report; the Chairman's statement to shareholders and Investment Manager's review includes a fair review of the information required by: 

(a) DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, being an indication of the important events that have occurred during the first six months of the financial year and their impact on the financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

(b) DTR 4.2.8R of the Disclosure Guidance and Transparency Rules, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the entity during that period, and any changes in the related party transactions described in the last annual financial report that could do so.

The Half-Yearly Financial Report for the six months ended 31 March 2019 was approved by the Board and the above responsibility statement has been signed on its behalf by:

 

Fiona Wollocombe

Chairman

22 May 2019

 

Condensed statement of comprehensive income

 

 

 

 

Six months ended

Six months ended

Year ended

 

31 March 2019

31 March 2018

30 September 2018

 

(unaudited)

(unaudited)

(audited)

 

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

(Losses)/gains on investments

-

(5,690)

(5,690)

-

5,432

5,432

-

7,924

7,924

Investment income

109

-

109

146

-

146

323

-

323

Other income

13

-

13

6

-

6

-

-

-

Investment management fee

(61)

(184)

(245)

(81)

(243)

(324)

(164)

(491)

(655)

 

Other expenses

(129)

-

(129)

(121)

(1)

(122)

(252)

(2)

(254)

(Loss)/return on ordinary activities before taxation

(68)

(5,874)

(5,942)

(50)

5,188

5,138

(93)

7,431

7,338

Taxation on ordinary activities

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

(Loss)/return on ordinary activities after taxation

(68)

(5,874)

(5,942)

(50)

5,188

5,138

(93)

7,431

7,338

(Loss)/return per share

(0.13)p

(11.06)p

(11.19)p

(0.09)p

9.76p

9.67p

(0.18)p

13.98p

13.80p

 

Notes:

 

The total column of this statement represents the profit and loss account of the Company.

 

All revenue and capital items in the above statement derive from continuing operations. No operations were acquired or discontinued during the period.

 

The net (loss)/return for the periods disclosed above represents the Company's total comprehensive income.

 

Condensed statement of financial position

 

 

 

As at

31 March 2019

(unaudited)

£'000

As at

31 March 2018

(unaudited)

£'000

As at

30 September 2018

(audited)

£'000

Non-current assets

 

 

 

Investments

20,868

31,737

28,226

Current assets

 

 

 

Debtors

183

 32

44

Cash and cash equivalents

 4,128

 8,622

6,202

Total assets

25,179

40,391

34,472

Creditors - amounts falling due within one year

(163)

(387)

(241)

Net assets

25,016

40,004

34,231

Capital and reserves

 

 

 

Share capital

 5,296

 5,315

5,315

Share premium

 2,828

 2,828

2,828

Capital reserve - realised

7,169

 12,067

9,411

Capital reserve - unrealised

 7,336

 17,315

14,241

Capital redemption reserve

 2,588

 2,569

2,569

Revenue reserve

(201)

(90)

(133)

Equity shareholders' funds

25,016

40,004

34,231

Net asset value per share

47.24p

75.27p

64.40p

 

 

 

Condensed statement of changes in equity

 

 

 

 

For the six months ended 31 March 2019 (unaudited)

 

 

Share

capital

£'000

Share

premium

£'000

Capital

reserve

- realised*

£'000

Capital

reserve

- unrealised

£'000

Capital

redemption

reserve

£'000

Revenue

reserve*

£'000

Total

£'000

At 30 September 2018

5,315

2,828

9,411

14,241

2,569

(133)

34,231

Repurchase of shares for cancellation

(19)

-

(84)

-

19

-

(84)

Loss on ordinary activities after taxation

-

-

(93)

(5,781)

-

(68)

(5,942)

Transfer on disposal of investments

-

-

1,124

 (1,124)

-

-

-

Dividends paid

-

-

(3,189)

-

-

-

(3,189)

At 31 March 2019

5,296

2,828

7,169

7,336

2,588

(201)

25,016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the six months ended 31 March 2018 (unaudited)

 

 

Share

capital

£'000

Share

premium

£'000

Capital

reserve

- realised*

£'000

Capital

reserve

- unrealised

£'000

Capital

redemption

reserve

£'000

Revenue

reserve*

£'000

Total

£'000

At 30 September 2017

5,315

2,828

11,015

17,431

2,569

(40)

39,118

Repurchase of shares for cancellation

-

-

-

-

-

-

-

Return/(loss) on ordinary activities after taxation

-

-

1,438

3,750

-

(50)

5,138

Transfer on disposal of investments

-

-

3,866

 (3,866)

-

-

-

Dividends paid

-

-

(4,252)

-

-

-

(4,252)

At 31 March 2018

5,315

2,828

12,067

17,315

2,569

(90)

40,004

 

 

 

 

 

 

 

 

         

 

 

 

For the year ended 30 September 2018 (audited)

 

 

Share

capital

£'000

Share

premium

£'000

Capital

reserve

- realised*

£'000

Capital

reserve

- unrealised

£'000

Capital

redemption

reserve

£'000

Revenue

reserve*

£'000

Total

£'000

At 30 September 2017

5,315

2,828

11,015

17,431

2,569

(40)

39,118

Return/(loss) on ordinary activities after taxation

-

-

3,116

4,315

-

(93)

7,338

Transfer on disposal of investments

-

-

7,505

 (7,505)

-

-

-

Dividends paid

-

-

(12,225)

-

-

-

(12,225)

At 30 September 2018

5,315

2,828

9,411

14,241

2,569

(133)

34,231

* The aggregate of these reserves, being £6,968,000, represents the distributable reserves of the Company at 31 March 2019 (31 March 2018: £11,977,000; 30 September 2018: £9,278,000).

 

 

Condensed statement of cash flows

 

 

 

Six months ended

31 March 2019

(unaudited)

£'000

Six months ended

31 March 2018

(unaudited)

£'000

Year ended

30 September 2018

(audited)

£'000

 

Cash used in operations

(320)

(112)

(576)

Interest received

13

6

20

Net cash generated from operating activities

(307)

(106)

(556)

Cash flow from investing activities

 

 

 

Purchases of investments

-

(750)

(1,387)

Sales of investments

1,506

6,689

13,329

Net cash from investing activities

1,506

5,939

11,942

Cash flow from financing activities

 

 

 

Repurchase of shares for cancellation

(84)

-

-

Dividends paid

(3,189)

(4.252)

(12,225)

Net cash used in financing activities

(3,273)

(4,252)

(12,225)

Net (decrease)/increase in cash and cash equivalents

(2,074)

1,581

(839)

Cash and cash equivalents at the start of the period

6,202

7,041

7,041

(Decrease)/increase in cash in the period

(2,074)

1,581

(839)

Cash and cash equivalents at the end of the period

4,128

8,622

6,202

 

 

 

Notes to the Half-Yearly Financial Report

 

1. Accounting policies

The condensed financial statements have been prepared in accordance with the Company's accounting policies as set out in the Annual Financial Report for the year ended 30 September 2018 and are presented in accordance with the Companies Act 2006 (the 'Act'), FRS 104 and the requirements of the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' ('SORP') issued by the Association of Investment Companies (the 'AIC') in November 2014 and updated in February 2018.

 

The financial information contained within this Half-Yearly Financial Report does not constitute statutory accounts as defined in Sections 434 to 436 of the Act. The financial information for the year ended 30 September 2018 has been extracted from the statutory accounts which have been filed with the Registrar of Companies. The Auditor's report on those accounts was not qualified and did not contain statements under sections 498(2) or (3) of the Act.

 

2. (Loss)/return per share

(Loss)/return per ordinary share has been calculated based on the weighted average number of ordinary shares in issue for the six months ended 31 March 2019 being 53,111,450 ordinary shares (31 March 2018: 53,150,516; 30 September 2018: 53,150,516).

 

3. Dividends

A special dividend for the six months ended 31 March 2019 of 1.00 pence per ordinary share (2018: 8.00 pence) has been declared and will be paid on 30 June 2019 (2018: 11 May 2018) to shareholders on the register at close of business on 31 May 2019 (2018: 13 April 2018).

 

An interim dividend for the six months ended 31 March 2019 of 2.00 pence per ordinary share (2018: 2.00 pence) has been declared and will be paid on 30 June 2019 (2018: 29 June 2018) to those shareholders on the register at close of business on 31 May 2019 (2018: 8 June 2018).

 

4. Fair value hierarchy

All investments are designated at fair value through profit or loss on initial recognition in accordance with FRS 102. The following table provides an analysis of these investments based on the fair value hierarchy as described below which reflects the reliability and significance of the information used to measure their fair value.

 

The disclosure is split into the following categories:

 

Level 1 - Investments with unadjusted quoted prices in an active market;

 

Level 2 - Investments whose fair value is based on inputs other than quoted prices that are either directly or indirectly observable;

 

Level 3 - Investments whose fair value is based on inputs that are unobservable (i.e. for which market data is unavailable).

 

 

31 March

2019

£'000

31 March

2018

£'000

30 September 2018

£'000

Level 1

18,907

30,555

25,926

Level 2

1,961

1,182

2,300

Total value of investments

20,868

31,737

28,226

 

5. Share capital

The net asset value per ordinary share has been calculated based on 52,960,516 ordinary shares in issue (31 March 2018: 53,150,516; 30 September 2018: 53,150,516).

 

In the six months ended 31 March 2019, 190,000 ordinary shares were bought back and cancelled at a total cost of £84,000. No ordinary shares were bought back and cancelled in the year ended 30 September 2018 or the period ended 31 March 2018.

 

A further 97,000 ordinary shares were bought back and cancelled on 17 May 2019, post balance sheet, at a cost of £43,000.

 

6. Related party transactions

Fees payable during the period to the Directors of the Company are considered to be related party transactions.

 

Directors fees payable for the six months ended 31 March 2019 was £31,500 (six months ended 31 March 2018: £31,500; twelve months ended 30 September 2018: £63,000) of which £nil (31 March 2018: £nil; 30 September 2018: £nil) was outstanding at the period end.

 

7. Transactions with the Investment Manager

The investment management fee payable to Artemis Fund Managers Limited for the six months ended 31 March 2019 was £245,000 (six months ended 31 March 2018: £324,000; twelve months ended 30 September 2018: £655,000) of which £101,000 (31 March 2018: £321,000; 30 September 2018: £159,000) was outstanding at the period end.

 

8. Principal risks and uncertainties

Pursuant to DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, the principal risks faced by the Company include general market price risk, liquidity risk, regulatory risk and operational risk.

 

These risks, which have not materially changed since the Annual Financial Report for the year ended 30 September 2018, and the way in which they are managed, are described in more detail in the Annual Financial Report which is available on the Company's website at artemisvct.co.uk.

 

Availability of Half-Yearly Financial Report

Copies of the Half-Yearly Financial Report for the six months ended 31 March 2019 will be sent to shareholders shortly and will also be available from the registered office at 6th Floor, Exchange Plaza, 50 Lothian Road, Edinburgh, EH3 9BY as well as on the Company's website at artemisvct.co.uk.

 

For further information, please contact:

 

Artemis Fund Managers Limited

Company Secretary

0131 225 7300

  

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR UUVWRKWAVURR
Date   Source Headline
30th Sep 20202:22 pmRNSResult of General Meeting
30th Sep 202011:22 amRNSNet Asset Value(s)
29th Sep 202011:26 amRNSNet Asset Value(s)
29th Sep 202011:08 amRNSUpdate on the winding-up of the Company
28th Sep 20203:45 pmRNSResignation of Director
28th Sep 202011:41 amRNSNet Asset Value(s)
25th Sep 202012:12 pmRNSNet Asset Value(s)
24th Sep 202011:08 amRNSNet Asset Value(s)
23rd Sep 202010:47 amRNSNet Asset Value(s)
22nd Sep 202011:12 amRNSNet Asset Value(s)
21st Sep 202012:27 pmRNSNet Asset Value(s)
18th Sep 202011:22 amRNSNet Asset Value(s)
17th Sep 202010:52 amRNSNet Asset Value(s)
16th Sep 202010:27 amRNSNet Asset Value(s)
15th Sep 202011:22 amRNSNet Asset Value(s)
14th Sep 202011:29 amRNSPublication of Circular
14th Sep 202011:03 amRNSNet Asset Value(s)
11th Sep 202012:07 pmRNSNet Asset Value(s)
10th Sep 202011:11 amRNSNet Asset Value(s)
9th Sep 202012:36 pmRNSNet Asset Value(s)
8th Sep 202011:42 amRNSNet Asset Value(s)
7th Sep 202012:07 pmRNSNet Asset Value(s)
4th Sep 202010:47 amRNSNet Asset Value(s)
3rd Sep 202011:06 amRNSNet Asset Value(s)
2nd Sep 202011:42 amRNSNet Asset Value(s)
1st Sep 202012:32 pmRNSNet Asset Value(s)
28th Aug 20205:18 pmRNSTotal Voting Rights
28th Aug 202011:27 amRNSNet Asset Value(s)
27th Aug 202011:27 amRNSNet Asset Value(s)
26th Aug 202011:38 amRNSNet Asset Value(s)
25th Aug 202012:02 pmRNSNet Asset Value(s)
24th Aug 202011:12 amRNSNet Asset Value(s)
21st Aug 202011:53 amRNSNet Asset Value(s)
20th Aug 202010:27 amRNSNet Asset Value(s)
19th Aug 202011:17 amRNSNet Asset Value(s)
18th Aug 202010:47 amRNSNet Asset Value(s)
17th Aug 202011:41 amRNSNet Asset Value(s)
14th Aug 202011:17 amRNSNet Asset Value(s)
13th Aug 202010:57 amRNSNet Asset Value(s)
12th Aug 202011:38 amRNSNet Asset Value(s)
12th Aug 20209:53 amRNSDividend Declaration
11th Aug 202011:36 amRNSNet Asset Value(s)
10th Aug 202011:07 amRNSNet Asset Value(s)
7th Aug 202011:23 amRNSNet Asset Value(s)
6th Aug 202011:22 amRNSNet Asset Value(s)
5th Aug 202010:13 amRNSNet Asset Value(s)
4th Aug 202011:02 amRNSNet Asset Value(s)
3rd Aug 202011:37 amRNSNet Asset Value(s)
31st Jul 20205:18 pmRNSTotal Voting Rights
31st Jul 202012:02 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.